MedTrace Logo

Use of Tranexamic Acid in the Total Knee Arthroplasty.

NCT05919615 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-06-26

No results posted yet for this study

Summary

Tranexamic acid is a medication used to treat or prevent excessive blood loss during surgery. Previous studies have shown tranexamic acid (TXA) reduces blood loss and post-operative blood transfusion rate without significant complications. In addition, many meta-analyses have confirmed these results. This study also aims to determine how safe and effective tranexamic acid treatment is for different patients undergoing primary total knee arthroplasty.

Conditions

Interventions

DRUG

Tranexamic Acid 100 MG/ML

Tranexamic Acid: 100 MG/ML Solution for injection

DRUG

Normal saline

0.9% sodium chloride normal saline

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Jaber Ibrahim, M.D, Ph.D · Damascus University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2023-03-15
Completion
2023-03-15

Countries

  • Syria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05919615 on ClinicalTrials.gov